The hidden impact of in-source fragmentation in metabolic and chemical mass spectrometry data interpretation

Martin Giera,Aries Aisporna,Winnie Uritboonthai,Gary Siuzdak

DOI: https://doi.org/10.1038/s42255-024-01076-x

IF: 19.865

2024-06-25

Nature Metabolism

Abstract:Mass spectrometry, specifically liquid chromatography–tandem mass spectrometry (LC–MS/MS), stands at the forefront of metabolomic, pharmaceutical and clinical analyses, offering high sensitivity and specificity in detecting metabolites and other small molecules within biological samples. Yet, this powerful technique has unveiled a puzzling abundance of unidentified spectral features, coined the 'dark metabolome' 1,2 , which starkly contrasts with the known metabolic diversity. While humans are known to host approximately 20,000 protein encoding genes 3,4 , with only a subset of these expressing enzymes, the presumed chemical diversity indicated by LC–MS/MS suggests hundreds of thousands to millions of metabolites remain to be characterized 2,5 . This discrepancy raises a crucial point: might there be a technological explanation inflating the perceived complexity instead of a biological one? The central dogma of biology describes the relation and information flow between the different omic layers from genome to transcriptome to proteome to metabolome, with the genome being the master code imprinted in any living system at its conception 6 . The code linking the first three layers is rather straightforward, with three nucleotides encoding one amino acid. However, such an encryption with the metabolome is yet to be revealed. This fact, combined with vast arrays of unannotated LC–MS/MS data, are two of the main reasons that the metabolome (being the entirety of small molecules within a biological system) cannot yet be defined. Current estimates suggest that less than 2% of observed LC–MS/MS spectra can be annotated, pointing to a potentially broad spectrum of unknown compounds 2 .

endocrinology & metabolism